Description of inefficiency variables that influence vegetable production. by James Anaba Akolgo (14129379)

Subjects:

Sample size distribution of dry-season vegetable farmers. by James Anaba Akolgo (14129379)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by gender, age standardized to the U.S. sta... by Shiying Hao (659634)

Subjects:

Summary of selected variables in frontier and inefficiency models. by James Anaba Akolgo (14129379)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021, age standardized to the U.S. standard popu... by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients and the 95% confidence intervals (CIs) for the chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by race/ethnicity, age standardized to the... by Shiying Hao (659634)

Subjects:

Gene expression changes in <i>lin-15(n744)</i> starved L1-stage animals. by Ashwin Seetharaman (615458)

Gene expression changes in <i>lin-35(n745)</i> starved L3-stage animals. by Ashwin Seetharaman (615458)

Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database. by Yu Zhang (12946)

Subjects:

Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3‑Hydroxypyridin-4(1<i>H</i>)‑ones with <i>N</i>‑Phenylamide QS Inhibitors by Hao-Zhong Long (19685972)

“…The hit compound <b>19l</b> (IC₅₀ = 0.33 ± 0.06 μM) demonstrated significant biofilm inhibition compared to previously reported 3-hydroxypyridin-4(1<i>H</i>)-one derivatives <i>in vitro</i>. …”

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

Subjects:

Additional file 1 of Short-term oral zinc supplementation enhances Natural Killer cell functionality and decreases circulating Innate Lymphoid Cell counts and frequencies in health... by Lara Amling (20882028)